Literature DB >> 31926939

Humanized mice as preclinical models for myeloid malignancies.

Rana Gbyli1, Yuanbin Song1, Stephanie Halene2.   

Abstract

Humanized mice have proven to be invaluable for human hematological translational research since they offer essential tools to dissect disease biology and to bridge the gap between pre-clinical testing of novel therapeutics and their clinical applications. Many efforts have been placed to advance and optimize humanized mice to support the engraftment, differentiation, and maintenance of hematopoietic stem cells (HSCs) and the human hematological system in order to broaden the scope of applications of such models. This review covers the background of humanized mice, how they are used as platforms to model myeloid malignancies, and the various current and potential approaches to further enhance their utilization in biomedical research.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokine humanization; Humanized mice; Immunodeficient mouse models; Myeloid malignancy; Pre-clinical studies; Xenotransplantation

Year:  2020        PMID: 31926939     DOI: 10.1016/j.bcp.2020.113794

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

Review 1.  Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation.

Authors:  Pia Sommerkamp; François E Mercier; Adam C Wilkinson; Dominique Bonnet; Paul E Bourgine
Journal:  Exp Hematol       Date:  2020-12-02       Impact factor: 3.084

Review 2.  Hematopoietic Stem Cells: Nature and Niche Nurture.

Authors:  Geoffrey Brown
Journal:  Bioengineering (Basel)       Date:  2021-05-15

Review 3.  The RARγ Oncogene: An Achilles Heel for Some Cancers.

Authors:  Geoffrey Brown; Kevin Petrie
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

4.  Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes.

Authors:  Nanni Schmitt; Johann-Christoph Jann; Eva Altrock; Johanna Flach; Justine Danner; Stefanie Uhlig; Alexander Streuer; Antje Knaflic; Vladimir Riabov; Qingyu Xu; Arwin Mehralivand; Iris Palme; Verena Nowak; Julia Obländer; Nadine Weimer; Verena Haselmann; Ahmed Jawhar; Ali Darwich; Cleo-Aron Weis; Alexander Marx; Laurenz Steiner; Mohamad Jawhar; Georgia Metzgeroth; Tobias Boch; Florian Nolte; Wolf-Karsten Hofmann; Daniel Nowak
Journal:  Leukemia       Date:  2021-06-25       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.